The Antiretroviral Speed Access Program Switch (ASAP-Switch) Study
NCT06375304
·
clinicaltrials.gov ↗
PHASE4
Phase
NOT_YET_RECRUITING
Status
50
Enrollment
OTHER
Sponsor class
Conditions
HIV Infections
Interventions
DRUG:
B/F/TAF
Sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre